Viagra for Women: The Little Pink Pill

Why won't the FDA approve this libido enhancing pill to treat female sexual dysfunction?
1:53 | 05/24/14

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

More information on this video
Enhanced full screen
Explore related content
Comments
Related Extras
Related Videos
Video Transcript
Transcript for Viagra for Women: The Little Pink Pill
Chantix is right for you. You know the commercials. For years now millions of men helped with a simple pill when it comes to romance. Tonight the controversy over another pill, this one some believe is a breakthrough in the same way for women. If it shows promise, why is the fda standing in the way? ABC's maria schiavocampo tonight. Reporter: When it comes to enhancing libido, there are plenty of options for men as we've all seen in those iconic viagra commercials. For women, not so much. There are currently no fda approved drugs for female sexual dysfunction. Cindy whitehead is trying to change that. She's the head of sprout pharmaceuticals. A company with just one single drug. It's the little pink pill? It's the little pink pill. Reporter: Known as viagra for women. It's real name is a less than sexy flibanserin and if approved would become the first drug of its kind on the market, specifically for treating hypoactive sexual desire disorder or hsdd affecting an estimated one in ten women who say they have no desires whatsoever. If you are married and you have no sexual desire but if Channing Tatum walks through the door everything changes do you have that condition? You do not. That's important. Reporter: Married mom Amanda parish says she has hsdd. After using flibanserin for a few weeks as part of a clinical trial, she says she noticed a definite difference. I became much more of an initiator and in turn we became much closer intimately. Reporter: Whitehead says most of the 1,000 women in the trial doubled their so-called satisfying sexual events and reported a 50% increase in sexual desire. After weighing the benefits and the risks, the fda made a big decision on the little pink pill, no. Sprout pharmaceuticals is appealing the decision and if they win flibanserin could be available as early as next year. Maria schiavocampo, ABC news, New York.

This transcript has been automatically generated and may not be 100% accurate.

{"id":23858389,"title":"Viagra for Women: The Little Pink Pill","duration":"1:53","description":"Why won't the FDA approve this libido enhancing pill to treat female sexual dysfunction?","section":"WNT","mediaType":"Default"}